CTOMS marks two decades of turning a private tragedy into a professional standard for those who carry the fight. Chris Kopp’s decision to build a company after the 2002 Canadian losses in Afghanistan was never just about selling kits; it was about embedding the hard-won lessons of combat medicine into every layer of the response chain—military, law enforcement, first responders, and the armed citizen who may be the only help available when seconds count. In an era when progressive jurisdictions treat tourniquets and hemostatic agents as suspect “military-grade” items, CTOMS quietly normalized the idea that every prepared individual has both the right and the responsibility to stop bleeding before the ambulance arrives.

That longevity matters for the 2A community because it proves the market rewards companies that treat self-reliance as a virtue rather than a threat. While some states still flirt with restricting the same pressure dressings and chest seals that CTOMS has refined for two decades, the company’s growth demonstrates that demand for life-saving tools rises in direct proportion to the erosion of police response times and the expansion of constitutional carry. The anniversary is therefore less a corporate milestone than a quiet rebuke to the notion that only government agents should own the means to preserve life under fire.

Looking ahead, CTOMS’ continued relevance hinges on whether the broader firearms culture fully internalizes the “stop the bleed” mindset that the company helped import from the battlefield. As more states recognize constitutional carry without training mandates, the gap between the armed citizen and the trained responder narrows only if individuals voluntarily close it with the same gear and knowledge CTOMS has spent twenty years perfecting. The company’s story is therefore a standing invitation: honor the fallen not with rhetoric, but with the tourniquet in your range bag and the skills to use it.